Biogen Idec (MM)
   
To register click here

Biogen Idec Stock Price BIIB

Company Description : A biotechnology company, which is engaged in the discovery, development, manufacturing and commercialization of innovative therapies. url: www.biogenidec.com

Name:
Biogen Idec (MM)
Symbol:
NASDAQ:BIIB
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
1.332.5254.1754.1754.1854.8853.3353.8824850557:22:02
To register Click hereRegister for free Biogen Idec stock prices.

UPDATE: Biogen 4Q Profit Up 48%; Offers Bright 2010 Forecast
Biogen Idec Inc.'s (BIIB) fourth-quarter earnings rose 48% on strength from its multiple sclerosis franchise and offered a bright outlook for 2010. The Cambridge, Mass., biotech company is making efforts to continue the sales growth of its core MS products, as it suffered from another setback to its pipeline. Meanwhile...

Free Biogen Idec Stock Charts

Biogen Idec Historical Stock Chart
Biogen Idec Historical Stock Chart
Biogen Idec Monthly Stock Chart
Biogen Idec Monthly Stock Chart
Biogen Idec Intraday stock chart
Biogen Idec Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

FREE Company Reports (BIIB) Free Annual Report - Click Here!

Get the Latest Biogen Idec stock Price, quotes, trades and FREE Biogen Idec stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Biogen Idec (BIIB) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Biogen Idec News & Message Board Discussion

Latest Biogen Idec News Headlines
DateTimeSource
HeadlineMore
02/09/201011:50AMDJNUPDATE: Biogen 4Q Profit Up 48%; Offers Bright 2010 Forecast
02/09/20109:35AMDJNBiogen: Heart Drug Data Doesn't Support Continued Development
02/09/20108:10AMDJNBiogen 4Q Profit Rises 48%; 2010 Forecast Above Street Views
02/09/20107:15AMBWBiogen Idec Reports Full Year and Fourth Quarter 2009 Results
02/08/20103:00PMBWMultiple Sclerosis Experts Join Biogen Idec’s Research and Development Team
02/08/20102:57PMDJNActivists Increasingly Like Biotechs But With Mixed Results
02/05/20105:58PMDJNBiogen Plans First Study For Earlier Use Of MS Drug Tysabri
02/05/20102:26PMDJN2nd UPDATE: FDA: Rare Brain Infection Rises With Tysabri Doses
02/05/201012:58PMDJNUPDATE: FDA: Rare Brain Infection Rises With Tysabri Doses
02/05/201012:18PMDJNFDA: Brain Infection Rises With Number Of Tysabri Infusions
01/28/20101:55PMDJNUPDATE: Icahn Plans Third Consecutive Biogen Proxy Fight
01/28/20109:41AMDJNIcahn Nominates Biogen Directors For Third Consecutive Year
Latest Message Board Discussions
DateTime
TitleMore
02/09/20108:34AM7:22AM Biogen Idec beats by $0.15, reports revs
01/25/20108:16AM1:46AM Biogen Idec issues statement on U.S. approval
07/22/20099:18PMSome general rules of investing:
07/22/20083:15PMBiogen Idec Inc. (Nasdaq: BIIB) Finds Strength with
02/13/200812:49AMNext bottom coming.
12/13/200710:36AMThe PE should be around 20-25 so
11/17/200712:48PMAlmost ready... let it bottom.

Biogen Idec Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Biogen Idec company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Biogen Idec Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  100 54.17 02/09/2010 3:19PM USD


 



Biogen Idec Stock Prices supplied by NASDAQ.
Free NASDAQ stock prices are delayed by at least 15 minutes. Realtime NASDAQ stock prices available.
The Spread Bet Centre :: The CFD Centre :: Financial Glossary :: Forex Rates, Charts & News
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright 1999-2010 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
34 site:2us nasdaq biib100209 15:34